cancer research
Physician Portal
physician portal
Patient Portal
cancer research at saficor

 Cancer Research at Saficor
In our cancer research effort at Saficor we use novel algorithms and biological assays for discovering effective anti-tumor compounds.

Safinur Project Safinur is a bi-molecular anti-tumor system that we are studying at Saficor. It is a broad spectrum anti-tumor agent that has shown promise in all solid tumors.

Cancer drug discovery lacks effective screening methods, which are needed to develop viable anti-tumor compounds. Most in vitro and in vivo screening assays do not guarantee that a compound will work in human trials. Of the thousands of compounds discovered almost none make it into the final phases of development. Even if some do make it, their efficacy is low and toxicity high. In the field of cancer drug therapeutics, researchers and healthcare professionals speak in terms of a month or two extra in survival instead of cures or real responses. There is no "gold standard" of treatment in the field of cancer therapeutics and most cancer therapies are palliative.

Our goal at Saficor is to change this reality with a fresh look at the cancer drug discovery method. We are introducing new paradigms in understanding the dynamics of cancer cell survival and tumor architecture to help us in discovering new anti-tumor compounds. One of our more advanced projects in the field of cancer research is the safinur project. You can learn about this project and the accompanying clinical study program from the above link.

Clinical Study: 


If you have any questions regarding information contained in this website, please give us a call at 714-532-4632 or email us at


Saficor, Technology, Business, Employment, Contact,
Cancer, Mechanism, Lab Studies, Toxicity,
Clinical Study, Registration, Patient Portal, Physician portal
Enrollment New Patients, Continuing Patients

Saficor, Orange, California USA; Copyright Saficor 2006 all rights reserved


 The information contained here is not intended as a substitute for medical professional help or advice but is to be used only for informational purposes. A physician should always be consulted for any health problem or medical condition. Safinur has not yet undergone organized clinical trials for cancer. It is provided as a dietary supplement for clinical study. Before taking this or other dietary supplements consult your physician. Safinur has been shown to be uniquely non-toxic in many animal studies; however, systematic human studies on toxicity have not been conducted. Statements made on this website have not been evaluated by the FDA and are not meant to diagnose, treat, cure or prevent any disease.

Saficor, Orange, California USA; Copyright Saficor 2006 all rights reserved